- Home
- APDN vs QLGN Comparison
APDN vs QLGN Comparison
Compare APDN & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APDN
- QLGN
- Stock Information
- Founded
- APDN 1983
- QLGN 1996
- Country
- APDN United States
- QLGN United States
- Employees
- APDN N/A
- QLGN N/A
- Industry
- APDN Other Consumer Services
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- APDN Consumer Discretionary
- QLGN Health Care
- Exchange
- APDN Nasdaq
- QLGN Nasdaq
- Market Cap
- APDN 2.0M
- QLGN 2.2M
- IPO Year
- APDN N/A
- QLGN N/A
- Fundamental
- Price
- APDN $0.84
- QLGN $3.48
- Analyst Decision
- APDN Strong Buy
- QLGN
- Analyst Count
- APDN 1
- QLGN 0
- Target Price
- APDN $75.00
- QLGN N/A
- AVG Volume (30 Days)
- APDN 1.5M
- QLGN 158.4K
- Earning Date
- APDN 05-09-2025
- QLGN 05-06-2025
- Dividend Yield
- APDN N/A
- QLGN N/A
- EPS Growth
- APDN N/A
- QLGN N/A
- EPS
- APDN N/A
- QLGN N/A
- Revenue
- APDN $3,736,873.00
- QLGN N/A
- Revenue This Year
- APDN $57.08
- QLGN N/A
- Revenue Next Year
- APDN $40.00
- QLGN N/A
- P/E Ratio
- APDN N/A
- QLGN N/A
- Revenue Growth
- APDN N/A
- QLGN N/A
- 52 Week Low
- APDN $0.72
- QLGN $2.85
- 52 Week High
- APDN $246.00
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- APDN 22.16
- QLGN 52.85
- Support Level
- APDN $0.82
- QLGN $3.10
- Resistance Level
- APDN $0.95
- QLGN $4.40
- Average True Range (ATR)
- APDN 0.15
- QLGN 0.40
- MACD
- APDN 0.17
- QLGN 0.05
- Stochastic Oscillator
- APDN 13.34
- QLGN 40.32
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.